GoodRx Holdings, Inc.
HealthcareNASDAQ:GDRX · NASDAQ Global Select
+$0.02 today
Vol 0.67M · Avg 1.63M
Balance Sheet
Inspect the capital base behind the business
Review assets, liabilities, equity, cash, and debt to judge whether the company has the financial position to support future returns.
Balance Sheet
Assets, liabilities & equity
| Cash & Equivalents | $235.7M |
| Receivables | $232.7M |
| Other Current | $798.0M |
| Total Current Assets | $1.3B |
| PP&E (Net) | $40.5M |
| Goodwill | $430.3M |
| Intangible Assets | $201.4M |
| Tax Assets | $53.0M |
| Other Non-current | $29.6M |
| Total Non-current Assets | $754.8M |
| Total Assets | $2.0B |
Analysis
Selected assets total $2.0B for Latest. The largest visible component is Other Current at $798.0M, about 39.5% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.
Balance Sheet
Annual data · 5 periods
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $261.8M -41.6% | $448.3M -33.3% | $672.3M -11.2% | $757.2M -19.5% | $941.1M | $1.0B | $841.8M | $673.8M |
| Short-term Investments | $0 | $0 | $0 | $0 | $0 | -$1.6B | $445.6M | $378.4M |
| Net Receivables | $254.9M +58.5% | $160.8M +0.5% | $160.0M +31.5% | $121.7M -3.8% | $126.4M | $533.8M | $399.4M | -$1.7B |
| Inventory | $0 | $0 | $0 | $0 | $0 | $641.6M | $328.0M | $316.8M |
| Other Current Assets | $126.4M +152.4% | $50.1M +23.8% | $40.4M +15.2% | $35.1M +64.8% | $21.3M | $1.5B | $966.4M | $764.8M |
| Total Current Assets | $643.1M -2.5% | $659.3M -24.5% | $872.8M -5.1% | $919.7M -15.5% | $1.1B | $12.5B | $10.5B | $5.5B |
| Property, Plant & Equipment (Net) | $41.1M +1.5% | $40.5M -11.8% | $45.9M -17.7% | $55.7M +13.0% | $49.3M | $1.2B | $1.5B | $687.8M |
| Goodwill | $430.3M +4.8% | $410.8M +0.0% | $410.8M -0.3% | $412.1M +25.0% | $329.7M | $925.8M | $466.6M | $309.8M |
| Intangible Assets | $203.3M +15.0% | $176.9M +13.1% | $156.3M -17.7% | $189.9M +42.0% | $133.8M | $568.8M | $860.0M | $1.5B |
| Long-term Investments | $0 | $0 | $0 | $0 | $0 | $524.0M | -$1.5B | $860.0M |
| Tax Assets | $57.1M -26.0% | $77.2M +18.3% | $65.3M | $0 | $0 | $1.5B | $1.4B | $1.4B |
| Other Non-current Assets | $29.1M +23.7% | $23.5M -37.7% | $37.8M +39.1% | $27.2M +352.2% | $6.0M | $1.4B | $1.0B | $679.4M |
| Total Non-current Assets | $761.0M +4.4% | $728.8M +1.8% | $716.0M +4.5% | $684.9M +32.0% | $518.8M | -$15.3B | $14.8B | $11.3B |
| Total Assets | $1.4B +1.2% | $1.4B -12.6% | $1.6B -1.0% | $1.6B -0.2% | $1.6B | $13.3B | $11.9B | $10.6B |
| Account Payables | $19.4M +37.3% | $14.1M -61.0% | $36.3M +104.9% | $17.7M +1.1% | $17.5M | $1.3B | -$1.5B | $1.4B |
| Short-term Debt | $5.0M +0.0% | $5.0M -43.1% | $8.8M +25.0% | $7.0M +0.0% | $7.0M | -$1.6B | -$1.6B | $326.6M |
| Tax Payables | $0 -100.0% | $1.5M | $0 | $0 | $0 | $574.4M | -$1.5B | $1.4B |
| Deferred Revenue | $6.7M +11.1% | $6.0M -15.0% | $7.1M -9.8% | $7.9M +14.7% | $6.9M | -$1.6B | $374.2M | $542.2M |
| Other Current Liabilities | $130.1M +723.8% | $15.8M | $0 | $0 | $0 | $1.1B | $1.5B | $493.2M |
| Total Current Liabilities | $246.0M +98.5% | $123.9M +1.1% | $122.6M +60.6% | $76.3M -5.9% | $81.1M | $6.0B | $10.1B | $14.3B |
| Long-term Debt | $483.3M -0.7% | $486.7M -24.9% | $647.7M -0.6% | $651.8M -0.6% | $655.9M | $1.3B | $438.6M | $1.3B |
| Deferred Tax Liabilities | $0 | $0 | $0 | $0 -100.0% | $244.0K | $746.6M | $612.2M | $477.8M |
| Deferred Revenue (Non-current) | $0 | $0 | $0 | $0 | $0 | -$1.6B | $715.8M | $1.3B |
| Other Non-current Liabilities | $8.7M +29.4% | $6.8M -17.4% | $8.2M +8.2% | $7.6M +47.1% | $5.1M | $489.0M | $1.1B | -$1.5B |
| Total Non-current Liabilities | $541.8M +0.4% | $539.5M -23.4% | $704.3M -1.3% | $713.5M +2.7% | $694.8M | $3.9B | $7.5B | $14.1B |
| Total Liabilities | $787.8M +18.7% | $663.4M -19.8% | $826.8M +4.7% | $789.8M +1.8% | $775.9M | $14.7B | $3.7B | $9.6B |
| Common Stock | $34.0K -10.5% | $38.0K -5.0% | $40.0K +0.0% | $40.0K +0.0% | $40.0K | $651.4M | $517.0M | $382.6M |
| Retained Earnings | -$1.4B +2.1% | -$1.4B +1.1% | -$1.5B -0.6% | -$1.4B -2.3% | -$1.4B | -$1.6B | $519.8M | $1.1B |
| Accumulated OCI | $0 | $0 | $0 | $0 | $0 | $393.8M | $550.6M | $707.4M |
| Other Stockholders Equity | $0 | $0 | $0 | $0 | $0 | $351.8M | -$1.6B | $1.5B |
| Minority Interest | $0 | $0 | $0 | $0 | $0 | $1.4B | $337.8M | $931.4M |
| Total Equity | $616.3M -15.0% | $724.7M -4.9% | $762.0M -6.5% | $814.8M -2.0% | $831.7M | $9.1B | $7.7B | $3.3B |
| Total Debt | $542.8M -0.1% | $543.4M -23.6% | $711.1M -0.8% | $717.0M +2.1% | $702.3M | $724.2M | $410.6M | $399.4M |
| Net Debt | $281.0M +195.6% | $95.0M +145.1% | $38.8M +196.6% | -$40.1M +83.2% | -$238.8M | $389.6M | $501.6M | $311.2M |
Older periods hidden.
Sign in to unlockCompetitors
Peer companies in the same sector
Pulse Biosciences, Inc.
NASDAQ:PLSE
$1.69B
Innoviva, Inc.
NASDAQ:INVA
$1.68B
AdaptHealth Corp.
NASDAQ:AHCO
$1.38B
IRadimed Corporation
NASDAQ:IRMD
$1.20B
Collegium Pharmaceutical, Inc.
NASDAQ:COLL
$1.12B
Amphastar Pharmaceuticals, Inc.
NASDAQ:AMPH
$885.83M
HealthStream, Inc.
NASDAQ:HSTM
$763.39M
MiMedx Group, Inc.
NASDAQ:MDXG
$536.20M
Claritev Corporation
NYSE:CTEV
$526.61M
LifeMD, Inc.
NASDAQ:LFMD
$227.30M
SEC Filings
Recent regulatory filings
No filings found.
How much cash does GDRX have?
GoodRx Holdings, Inc. (GDRX) reported $261.82M in cash and equivalents in fiscal 2025.
How much debt does GDRX carry?
GoodRx Holdings, Inc. (GDRX) reported $542.81M of total debt, with net debt of $280.99M.
Explore More
Continue the stock analysis
Jump to another research area for this company.